Fusobacterium in colonic flora and molecular features of colorectal carcinoma
- PMID: 24385213
- PMCID: PMC4396185
- DOI: 10.1158/0008-5472.CAN-13-1865
Fusobacterium in colonic flora and molecular features of colorectal carcinoma
Abstract
Fusobacterium species are part of the gut microbiome in humans. Recent studies have identified overrepresentation of Fusobacterium in colorectal cancer tissues, but it is not yet clear whether this is pathogenic or simply an epiphenomenon. In this study, we evaluated the relationship between Fusobacterium status and molecular features in colorectal cancers through quantitative real-time PCR in 149 colorectal cancer tissues, 89 adjacent normal appearing mucosae and 72 colonic mucosae from cancer-free individuals. Results were correlated with CpG island methylator phenotype (CIMP) status, microsatellite instability (MSI), and mutations in BRAF, KRAS, TP53, CHD7, and CHD8. Whole-exome capture sequencing data were also available in 11 cases. Fusobacterium was detectable in 111 of 149 (74%) colorectal cancer tissues and heavily enriched in 9% (14/149) of the cases. As expected, Fusobacterium was also detected in normal appearing mucosae from both cancer and cancer-free individuals, but the amount of bacteria was much lower compared with colorectal cancer tissues (a mean of 250-fold lower for Pan-fusobacterium). We found the Fusobacterium-high colorectal cancer group (FB-high) to be associated with CIMP positivity (P = 0.001), TP53 wild-type (P = 0.015), hMLH1 methylation positivity (P = 0.0028), MSI (P = 0.018), and CHD7/8 mutation positivity (P = 0.002). Among the 11 cases where whole-exome sequencing data were available, two that were FB-high cases also had the highest number of somatic mutations (a mean of 736 per case in FB-high vs. 225 per case in all others). Taken together, our findings show that Fusobacterium enrichment is associated with specific molecular subsets of colorectal cancers, offering support for a pathogenic role in colorectal cancer for this gut microbiome component.
©2014 AACR
Figures
![Fig.1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4396185/bin/nihms-552636-f0001.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4396185/bin/nihms-552636-f0002.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4396185/bin/nihms-552636-f0003.gif)
Similar articles
-
Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.J Pathol. 2006 Oct;210(2):147-54. doi: 10.1002/path.2030. J Pathol. 2006. PMID: 16850502
-
Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.Int J Cancer. 2015 Sep 15;137(6):1258-68. doi: 10.1002/ijc.29488. Epub 2015 Mar 13. Int J Cancer. 2015. PMID: 25703934
-
Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators.Gastroenterology. 2014 Feb;146(2):530-38.e5. doi: 10.1053/j.gastro.2013.10.060. Epub 2013 Nov 6. Gastroenterology. 2014. PMID: 24211491 Free PMC article.
-
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.World J Gastroenterol. 2016 Jan 14;22(2):557-66. doi: 10.3748/wjg.v22.i2.557. World J Gastroenterol. 2016. PMID: 26811607 Free PMC article. Review.
-
Fusobacterium's link to colorectal neoplasia sequenced: A systematic review and future insights.World J Gastroenterol. 2017 Dec 28;23(48):8626-8650. doi: 10.3748/wjg.v23.i48.8626. World J Gastroenterol. 2017. PMID: 29358871 Free PMC article. Review.
Cited by
-
Insights into the oral microbiota in human systemic cancers.Front Microbiol. 2024 May 2;15:1369834. doi: 10.3389/fmicb.2024.1369834. eCollection 2024. Front Microbiol. 2024. PMID: 38756728 Free PMC article. Review.
-
Biofilms and core pathogens shape the tumor microenvironment and immune phenotype in colorectal cancer.Gut Microbes. 2024 Jan-Dec;16(1):2350156. doi: 10.1080/19490976.2024.2350156. Epub 2024 May 10. Gut Microbes. 2024. PMID: 38726597 Free PMC article.
-
Fusobacterium nucleatum infection modulates the transcriptome and epigenome of HCT116 colorectal cancer cells in an oxygen-dependent manner.Commun Biol. 2024 May 8;7(1):551. doi: 10.1038/s42003-024-06201-w. Commun Biol. 2024. PMID: 38720110 Free PMC article.
-
Cancer invasion and anaerobic bacteria: new insights into mechanisms.J Med Microbiol. 2024 Mar;73(3):001817. doi: 10.1099/jmm.0.001817. J Med Microbiol. 2024. PMID: 38535967 Free PMC article. Review.
-
Microbiota in colorectal cancer related to liver metastasis.Chin J Cancer Res. 2024 Feb 29;36(1):17-24. doi: 10.21147/j.issn.1000-9604.2024.01.02. Chin J Cancer Res. 2024. PMID: 38455371 Free PMC article.
References
-
- Signat B, Roques C, Poulet P, Duffaut D. Fusobacterium nucleatum in periodontal health and disease. Curr Issues Mol Biol. 2011;13:25–36. - PubMed
-
- Swidsinski A, Dörffel Y, Loening-Baucke V, et al. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut. 2011;60:34–40. - PubMed
-
- Strauss J, Kaplan GG, Beck PL, et al. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis. 2011;17:1971–1978. - PubMed
-
- Neut C, Bulois P, Desreumaux P, et al. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn’s disease. Am J Gastroenterol. 2002;97:939–946. - PubMed
-
- Ohkusa T, Sato N, Ogihara T, Morita K, Ogawa M, Okayasu I. Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody. J Gastroenterol Hepatol. 2002;17:849–853. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous